Dermal Fillers Market Research Report Information By Type (Hyaluronic Acid, Polymers & Particles, Calcium Hydroxylapatite, and Collagen), By Application (Facial Line Correction Treatment, Face-Lift, and Lip Treatments), By Brands (Juvederm, Radiesse, and Restylane) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

Global Dermal Fillers Market Overview

The Dermal Fillers Market Size was estimated at USD 5.1 Billion in 2022 and is projected to grow from USD 5.50 Billion in 2023 to USD 10.11 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.90% during the forecast period (2023 - 2032). Increased interest in plastic surgery and the growing need for minimally invasive techniques are key market drivers contributing to market growth and revenue. 

According to MRFR's study of the dermal filler market, the rising popularity of cosmetic surgery is anticipated to be a key driver of market growth throughout the forecast period. It is projected that during the projection period, increasing face operations performed on both men and women would have a significant impact on the market's growth. In addition, main players' ongoing technical advancement in dermal fillers is anticipated to be advantageous for the sector in the coming years. During the review period, the market has had a considerable opportunity due to the rising demand for less invasive procedures. To match the rising demand, industrialists are introducing a variety of cutting-edge items, which is predicted to stimulate growth in the upcoming assessment period. However, the negative effects of such fillers are projected to constitute a major obstacle to the market's growth in the near future.

Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

Dermal Fillers Market Trends

• The growing interest in plastic surgery is driving the market growth

The rising interest in plastic surgery drives Market CAGR for dermal fillers. The increasing number of face surgeries performed by both men and women is expected to impact the market's development over the evaluation period significantly. Recently, individuals have searched for less invasive and less painful treatments to achieve a more youthful and healthier appearance. Because invasive cosmetic operations can have a variety of hazards and also demand the patient take more time to recuperate from the surgery. American Society of Plastic Surgeons reported that roughly $13.2 Mn aesthetic operations were performed in the US, with collagen fillers accounting for $3.4 Mn of those treatments in 2020. Such compelling figures demonstrate the considerable growth in demand for cosmetic operations.

Additionally, the market saw substantial potential due to the increasing demand for less invasive procedures. Businesses are releasing a variety of novel items to fulfill rising demand, which is expected to increase the rate of growth in the future years. One of the major advancements in the worldwide industry is that practically every demographic has expressed a curiosity for these non-intrusive or minimally invasive treatments. This is especially true for men, who increasingly use cosmetic operations to improve their appearance. A rising number of men are discovering that aging and gravity may harm how they look at their facial characteristics. As a result, males are turning to face filler treatments for their efficiency in wrinkle reduction.

Furthermore, technical advancements in medical cosmetic supplies drive market expansion. A rise in unhealthy habits has resulted in early aging, leaving people self-conscious about their looks and increasing the demand for dermal filler treatments. Moreover, cosmetic procedures are employed in various uses, such as lip enlargement, cheek volume reconstruction, and face revitalization, which increases the requirement for dermal filler goods.

The coronavirus epidemic is expected to have a detrimental influence on the worldwide market. The market is anticipated to decline by 40% in 2020 compared to 2019. Several cosmetic establishments and clinics were closed during the worldwide shutdown. The increasing prevalence of coronavirus limits the number of cosmetic procedures, which negatively influences the growth of the dermal fillers industry. The economy rebounded following the pandemic in 2021, as the globe gradually relaxed the COVID-19 rules due to a decrease in the overall number of confirmed cases. Major firms such as AbbVie Inc. and Revance Therapeutics saw an increase in their aesthetics offering as consumer interest in injectable therapies increased internationally.

For instance, the International Society of Aesthetic Plastic Surgery estimated 4,315,859 hyaluronic acid filler treatments were performed worldwide in 2019. This represents a 15.7% rise over the comparable period of 2018. A rise in aesthetic operations is also predicted to contribute to market growth. Therefore, it is anticipated that demand for Dermal Fillers will increase throughout the projection period due to the rising interest in plastic surgery. Thus, driving the Dermal Fillers market revenue.

Dermal Fillers Market Segment Insights

Dermal Fillers Type Insights

The market segments of dermal fillers, based on type, includes hyaluronic acid, polymers & particles, calcium hydroxylapatite, and collagen. The hyaluronic acid category dominated the market, accounting for 35% of market revenue (USD 1.8 Billion) in 2022. The growing market for hyaluronic acid and products based on it is mostly due to its safety and durability. In addition, significant firms providing hyaluronic acid treatments in rapidly expanding regions will boost the overall market growth.

Dermal Fillers Application Insights

The dermal fillers market segmentation, based on application, includes facial line correction treatment, face-lift, and lip treatments. The lip treatments category generated the most income of about 47% (USD 2.4 billion) in 2022. An increasing desire for aesthetic attractiveness and increased beauty sensitivity within women, led by the growth of less invasive treatments, are expected to propel the sectors throughout the projected timeframe.

Figure 1: Dermal Fillers Market, by Application, 2022 & 2032 (USD Billion) 

Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

Dermal Fillers Brand Insights

The market segmentation of dermal fillers, based on brand, includes juvederm, radiesse, and restylane. The juvederm dominated the market, accounting for 45% of market revenue (USD 2.2 Billion) in 2022. The Restylane category is expected to grow quickly during the projected timeframe.

Dermal Fillers Regional Insights

By region, the research provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The North American Dermal Fillers market will dominate, owing to increased demand for cosmetic solutions and the growing use of non-invasive or partially invasive procedures in this region. In addition, expanding clinical studies into developing novel skin-friendly beauty items will boost the market growth during the projected timeframe.

Further, the major countries studied in the market report are the US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2: Dermal Fillers Market Share by Region 2022 (USD Billion) 

Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

Europe region’s Dermal Fillers market accounts for the second-largest market share due to the increased requirement for minimally invasive procedures to enhance facial beauty, along with the approval of products and accessibility throughout the area will boost market share. Further, the German market of Dermal Fillers dominates the market share, and the UK market of Dermal Fillers is anticipated to grow rapidly in the European region during the projected timeframe.

The Asia-Pacific Dermal Fillers Market is anticipated to grow significantly during the projected timeframe because of the increased need for aesthetically pleasing facial items and non-invasive cosmetic treatments, boosting market demand in the APAC region. Moreover, China’s market of Dermal Fillers holds the largest market share, and the Indian market of Dermal Fillers is anticipated to expand rapidly in the Asia-Pacific region.

Dermal Fillers Key Market Players & Competitive Insights

Leading market players invested heavily in research and development (R&D) to scale up their manufacturing units and product lines, which will help the market of Dermal Fillers to grow and expand worldwide. Market participants are also undertaking various organic or inorganic strategic approaches to strengthen and expand their footprint, with important market developments including new product portfolios, contractual deals, mergers and acquisitions, capital expenditure, higher investments, and strategic alliances with other organizations. Businesses are also coming up with marketing strategies such as digital marketing, social media influencing, and content marketing to increase their scope of profit earnings. The Dermal Fillers industry must offer cost-effective and sustainable options to survive in a dynamic market.

Manufacturing locally to minimize operational expenses is a key business strategy manufacturers use in the Dermal Fillers industry to benefit customers and capture untapped market share and revenue. The Dermal Fillers industry has recently offered significant advantages to the medicine and service industry. Major players in the Dermal Fillers market, including Galderma Laboratories, LP (Switzerland), Allergan (Ireland), Merz Pharma (Germany), Dr. Korman Laboratories (Israel), Sinclair Pharma (UK), Teoxane Laboratories (Switzerland), Suneva Medical (US), SciVision Biotech Inc. (Taiwan), Medytox (South Korea), are attempting to expand market share and demand by investing in research and development (R&D) operations to produce sustainable and affordable solutions.

Sinclair Pharma is a multinational aesthetics firm headquartered in London, a subsidiary of Huadong Medicine Ltd. The firm provides a range of complementary cosmetic pharmaceutical medicines emphasizing collagen stimulation for excellent quality, long-lasting, and minimally intrusive treatments. Sinclair Pharma reported in April 2022 that Perfectha Lidocaine was granted the European CE mark for its use in wrinkle reduction, face contouring, and density regeneration. This CE accreditation allows Perfectha Lidocaine to launch in the UK and with all significant European markets.

Allergan Aesthetics, an AbbVie subsidiary, creates, produces, and sells top companies and goods such as face injections, figure contouring, and cosmetic surgery. Allergan's collection includes the most complete, rooted-in-science aesthetic solutions in the market. Allergan Aesthetics, an AbbVie subsidiary, partnered with Luminera, a privately owned aesthetics firm with a product line and pipeline of superficial filler products, in October 2020. According to the terms of the agreement, Allergan Aesthetics acquired Luminera's entire dermal filler portfolio and its research and development pipeline, significantly boosting its top dermal filler offering with its Juvederm filler assortment.

Key Companies in the market of Dermal Fillers include

• Galderma Laboratories LP (Switzerland)


• Allergan (Ireland)


• Merz Pharma (Germany)


• Dr. Korman Laboratories (Israel)


• Sinclair Pharma (UK)


• Teoxane Laboratories (Switzerland)


• Suneva Medical (US)


• SciVision Biotech Inc (Taiwan)


• Medytox (South Korea)

Dermal Fillers Industry Developments

April 2022:Sinclair Pharma reported in April 2022 that Perfectha Lidocaine was granted the European CE mark for its use in wrinkle reduction, face contouring, and density regeneration. This CE accreditation allows Perfectha Lidocaine to launch in the UK and with all significant European markets.

February 2021:Allergan Aesthetica, along with CollPlant, established a research and worldwide commercial partnership in February 2021 to utilize their plant-based recombinant human collagen (rhCollagen) in conjunction with Allergan's unique technologies to create and commercialize dermal and connective tissue fillers.

October 2020:Allergan Aesthetics, an AbbVie subsidiary, established a partnership with Luminera, a privately owned aesthetics firm having a product line and pipeline of superficial filler products, in October 2020. According to the terms of the agreement, Allergan Aesthetics acquired Luminera's entire dermal filler portfolio and its research and development pipeline, significantly boosting its top dermal filler offering with its Juvederm filler assortment.

May 2023: Evolus, Inc., a performance beauty company with a customer-centric strategy committed to delivering ground-breaking products, announced it has entered into a definitive agreement to be the sole U.S. distributor, Symatese, of a line of five distinctive dermal fillers currently in late-stage development. This filler line, EvolysseTM, is extremely competitive and works well with our rapidly expanding aesthetic neurotoxin, Jeuveau. The mainstay of aesthetics are injectables, with neurotoxins and dermal fillers ranking as the top two cosmetic procedures in the United States.

April 2022: Sinclair Pharma declared that Perfectha Lidocaine, a product used to treat wrinkles, facial contouring, and volume restoration, now carries the European CE mark. Perfectha Lidocaine is now available in the UK and all major European markets thanks to this CE accreditation.

Dermal Fillers Market Segmentation

Dermal Fillers Type Outlook

• Hyaluronic acid


• Polymers & particles


• Calcium hydroxylapatite


• Collagen

Dermal Fillers Application Outlook

• Facial Line Correction Treatment


• Face-Lift


• Lip Treatments

Dermal Fillers Brand Outlook

• Juvederm


• Radiesse


• Restylane

Dermal Fillers Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America
  
  
  
  

Report Scope:

Report Attribute/Metric	Details
Market Size 2022	USD 5.1 Billion
Market Size 2023	USD 5.50 Billion
Market Size 2032	USD 10.11 Billion
Compound Annual Growth Rate (CAGR)	7.90% (2023-2032)
Base Year	2022
Market Forecast Period	2023-2032
Historical Data	2018- 2022
Market Forecast Units	Value (USD Billion)
Report Coverage	Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
Segments Covered	Type, Application, Brand, and Region
Geographies Covered	North America, Europe, Asia Pacific, and the Rest of the World
Countries Covered	The US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
Key Companies Profiled	Galderma Laboratories, LP (Switzerland), Allergan (Ireland), Merz Pharma (Germany), Dr. Korman Laboratories (Israel), Sinclair Pharma (UK), Teoxane Laboratories (Switzerland), Suneva Medical (US), SciVision Biotech Inc. (Taiwan), Medytox (South Korea)
Key Market Opportunities	The growing need for minimally invasive techniques will provide substantial growth potential throughout the projected timeframe.
Key Market Dynamics	Increased interest in plastic surgery will drive dermal fillers to expand over the projected period.

Frequently Asked Questions (FAQ) :